MTOR anticorps (AA 1720-2020)
Aperçu rapide pour MTOR anticorps (AA 1720-2020) (ABIN2308359)
Antigène
Voir toutes MTOR (mTOR) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 1720-2020
-
Réactivité croisée
- Humain, Souris
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu Mo
-
Attributs du produit
- mTOR (mTAb1, Mammalian Target of Rapamycin, FRAP, RAFT)
-
Purification
- Purified by Protein G affinity chromatography.
-
Immunogène
- Recombinant corresponding to aa1720-2020 of human TOR expressed in E. coli (NP_004949).
-
Isotype
- IgG2a
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Reconstitute with 200 μL sterile PBS.
-
Buffer
- Supplied as a lyophilized powder from a 0.2um filtered solution in PBS with 5 % trehalose.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- MTOR (mTOR) (Mechanistic Target of Rapamycin (serine/threonine Kinase) (mTOR))
-
Autre désignation
- mTOR
-
Pathways
- Signalisation PI3K-Akt, Signalisation RTK, AMPK Signaling, Interferon-gamma Pathway, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Actin Filament Polymerization, Regulation of Muscle Cell Differentiation, Regulation of Cell Size, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Autophagy, CXCR4-mediated Signaling Events, BCR Signaling, L'effet Warburg
Antigène
-